Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
The Covid-19 pandemic continues to grip the world this summer, with many lockdown restrictions remaining…
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to…
Public and private organizations across Europe will pool their resources in an €80M project to…
Diabetes has become an epidemic, sentencing over 422 million people worldwide to lifelong medication. Science…
Sanofi has signed a licensing deal with French biotech Biomunex, whose antibody technology has the potential…
Sanofi is to make an €80M equity investment in the German biotech BioNTech, and the two…
Ablynx, one of the big giants in the European biotech arena, closed the final stages…
Evotec will be getting over 10 assets, €60M upfront and about 100 scientists from Sanofi's…
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
Experts say hemophilia treatment is at a 'precipice of a therapeutic revolution.' From antibodies to…